[{"NetIncomeLoss_1_Q2_USD":-29900000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":3000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":40000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-15243000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"MarketableSecuritiesCurrent_0_Q2_USD":124683000.0,"InventoryGross_0_Q2_USD":96081000.0,"DepreciationAndAmortization_2_Q2_USD":1726000.0,"DepreciationAndAmortization_1_Q2_USD":900000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":74203858.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":75559697.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":54899000.0,"InventoryFinishedGoods_0_Q2_USD":44073000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-267000.0,"Liabilities_0_Q2_USD":583322000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":440000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-261890000.0,"PurchaseObligation_0_Q2_USD":73963000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":40903000.0,"ProvisionForLoanLossesExpensed_1_Q2_USD":0.0,"ProvisionForLoanLossesExpensed_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":660013000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":79736000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":40345000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":24207000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":16696000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":37309256.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":37335701.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":4009000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q2_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":329738000.0,"OtherAssetsNoncurrent_0_Q2_USD":10423000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q2_USD":18151000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-29860000.0,"LongTermLoansPayable_0_Q2_USD":63420000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":258258000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":54766000.0,"GainLossOnContractTermination_2_Q2_USD":-3210000.0,"InventoryRawMaterials_0_Q2_USD":4922000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-2335000.0,"EarningsPerShareBasic_1_Q2_USD":-0.4,"EarningsPerShareBasic_2_Q2_USD":-2.73,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":74203858.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":75559697.0,"PurchaseObligationDueInSecondYear_0_Q2_USD":9753000.0,"LoansPayableCurrent_0_Q2_USD":11538000.0,"ProceedsFromStockPlans_2_Q2_USD":1985000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":72000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":11000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncreaseDecreaseInInventories_2_Q2_USD":3860000.0,"ConvertibleNotesPayableCurrent_0_Q2_USD":80605000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_1_Q2_USD":0.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":15000000.0,"CostsAndExpenses_1_Q2_USD":111807000.0,"CostsAndExpenses_2_Q2_USD":362201000.0,"CommonStockSharesIssued_0_Q2_shares":76464700.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":49291000.0,"NetIncomeLossAttributableToParentDiluted_1_Q2_USD":-29900000.0,"NetIncomeLossAttributableToParentDiluted_2_Q2_USD":-202847000.0,"CommonStockValue_0_Q2_USD":7000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q2_USD":30512000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q2_USD":27281000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-202844000.0,"Assets_0_Q2_USD":739542000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-202847000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-29900000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1730000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11512000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":0.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":40000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1179000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":74203858.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":75559697.0,"InventoryWorkInProcess_0_Q2_USD":47086000.0,"LiabilitiesCurrent_0_Q2_USD":287052000.0,"AccountsPayableCurrent_0_Q2_USD":14568000.0,"InterestExpense_2_Q2_USD":11395000.0,"InterestExpense_1_Q2_USD":5747000.0,"Goodwill_0_Q2_USD":943000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":330178000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":8446000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":10108000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2620000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_security":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":74203858.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":75559697.0,"AdditionalPaidInCapital_0_Q2_USD":1122081000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1985000.0,"ConvertibleSubordinatedDebtNoncurrent_0_Q2_USD":223655000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"InventoryNoncurrent_0_Q2_USD":56413000.0,"ReceivablesNetCurrent_0_Q2_USD":141825000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-313000.0,"NetIncomeLoss_2_Q2_USD":-202847000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8940000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":140330000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"EarningsPerShareDiluted_1_Q2_USD":-0.4,"InterestExpenseRelatedParty_2_Q2_USD":1265000.0,"InterestExpenseRelatedParty_1_Q2_USD":634000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":40903000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q2_USD":9130000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3556000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-773000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"OperatingIncomeLoss_2_Q2_USD":-191524000.0,"OperatingIncomeLoss_1_Q2_USD":-24164000.0,"InventoryNet_0_Q2_USD":39668000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":739542000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":14816000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":2064000.0,"EarningsPerShareDiluted_2_Q2_USD":-2.73,"CommonStockSharesOutstanding_0_Q2_shares":76464700.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-211420000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-965601000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":87643000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":170677000.0,"ShareBasedCompensation_2_Q2_USD":28479000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-649000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":30257000.0,"StockholdersEquity_0_Q2_USD":156220000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":751000.0,"ProfitLoss_2_Q2_USD":-202847000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":26461000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":342000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":560000.0,"PurchaseObligationDueInThirdYear_0_Q2_USD":3441000.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]